Could SARS-CoV-2 herald a surge of multiple sclerosis?

The Egyptian Journal of Neurology, Psychiatry and Neurosurgery

Hatem Samir Shehata¹  Nevin Mohieldin Shalaby¹ 

[1] Neurology Department, Kasr Al-Ainy School of Medicine, Cairo University, Department No.15, Second Floor, Al-Saraya St., Al-Manial District, Cairo, Egypt;

关键词: COVID-19;    SARS-CoV-2;    Multiple sclerosis;    Neurotropism;   

DOI  :  10.1186/s41983-021-00277-5

来源: Springer

【 摘 要 】

During the current COVID-19 pandemic, many queries are raised regarding its nature, outcome, and sequelae. This letter raises the concern of potential impact on increasing the incidence of multiple sclerosis whose pathology involves a possible viral etiology. Besides, the potential neurotropism of the acute respiratory distress syndrome corona virus-2 (SARS-CoV-2), which is still not established, may raise concerns about the use of certain disease modifying therapies namely natalizumab.

【 授权许可】

CC BY